We are committed to transforming the lives of people affected by cancer or rare disease, globally. We continuously strive to uncover opportunities which address gaps across adult and paediatric care.

Helping the people with few or no options available is at the heart of everything we do. 

EUSA Pharma is part of Recordati Rare Diseases (recordatirarediseases.com), the business unit dedicated to rare disease in the Recordati group. 

Recordati has a total staff of more than 4,300, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. More information can be found in the press release: https://www.recordati.com/resources/Pubblicazione/___58a6bc05f57c4861aae203c930cd1682_/eusa-closing-pr.pdf

We see a need. We work together. We don’t give up.


Health Care

Pharmaceutical

EUSA Pharma

Nathalie Magee

Eric Hurel

Ignacio Alvarez

Alvina To

Frankie S.

Janet Otts-Watson

Gaël le Rouzo

Aurélien Millet

Rick Baker

Lesley Watson

The Medical and Regulatory Affairs team at EUSA Pharma plays a critical role in ensuring the safety, efficacy, and compliance of our pharmaceutical products targeting cancer and rare diseases. They manage clinical trials, oversee regulatory submissions, and support scientific communication. This team is essential in bridging the gap between research and patient care, making sure treatments meet stringent regulatory standards while effectively addressing unmet medical needs.

Medical and Regulatory Affairs

Market Access and Sales

Finance & Accounting Team

Medical and Regulatory Affairs

About

Team members

Other teams at EUSA Pharma

Market Access and Sales

Finance & Accounting Team